October 4, 2022
Voyager Therapeutics Licenses Next-Generation AAV Capsid to Pfizer for Rare Neurologic Disease Target
Read More
October 4, 2022
Sanofi Enters Strategic Collaboration with MiRecule for Antibody-RNA Conjugate to Treat FSHD
Read More
October 3, 2022
Alexion, AstraZeneca Rare Disease to Acquire LogicBio to Accelerate Growth in Genomic Medicine
Read More
September 30, 2022
Solid Biosciences Acquires AavantiBio and Raises $75 Million in Private Placement
Read More
September 30, 2022
Vanda and OliPass Partner to Develop Antisense Oligonucleotide Therapeutics
Read More
September 29, 2022
Looking to Stay Afloat, Idera Acquires Rare Disease Biotech Aceragen
Read More
September 20, 2022
Rocket to Acquire Renovacor, Adding AAV-based Cardiac Gene Therapy to Pipeline
Read More
September 19, 2022
Genfit to Acquire Versantis, Expanding its Portfolio in Liver Diseases
Read More
September 14, 2022
Nacuity Enters Licensing Agreement and Strategic Partnership with Arctic for HCCAA Therapy
Read More
September 12, 2022
Invitae and Simons Searchlight Partner to Accelerate Research through Data Sharing
Read More
September 9, 2022
Imara Enters Asset Purchase Agreement with Cardurion for Failed Sickle Cell Drug Candidate
Read More
September 7, 2022
Oxford Nanopore Launches Pilot Program with Al Jalila Children’s Specialty Hospital to Diagnose Rare Genetic Diseases
Read More
Load More
X